Amphastar Ownership
| AMPH Stock | USD 20.62 1.08 4.98% |
Shares in Circulation | First Issued 2012-03-31 | Previous Quarter 52.1 M | Current Value 49.9 M | Avarage Shares Outstanding 44.3 M | Quarterly Volatility 12.4 M |
Amphastar | Build AI portfolio with Amphastar Stock |
Amphastar Stock Ownership Analysis
About 24.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.29. Some equities with similar Price to Book (P/B) outperform the market in the long run. Amphastar P has Price/Earnings To Growth (PEG) ratio of 2.77. The entity last dividend was issued on the June 11, 2010. Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Amphastar Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1761 people. For more info on Amphastar P please contact the company at 909 980 9484 or go to https://www.amphastar.com.Besides selling stocks to institutional investors, Amphastar also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Amphastar's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Amphastar's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Amphastar Quarterly Liabilities And Stockholders Equity |
|
Amphastar Insider Trades History
About 24.0% of Amphastar P are currently held by insiders. Unlike Amphastar's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Amphastar's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Amphastar's insider trades
Amphastar Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Amphastar is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amphastar P backward and forwards among themselves. Amphastar's institutional investor refers to the entity that pools money to purchase Amphastar's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2025-03-31 | 594.4 K | Federated Hermes Inc | 2025-03-31 | 585.1 K | T. Rowe Price Associates, Inc. | 2025-03-31 | 541.2 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 522.1 K | Renaissance Technologies Corp | 2025-03-31 | 495 K | Pacer Advisors, Inc. | 2025-03-31 | 479.4 K | Boston Partners Global Investors, Inc | 2025-03-31 | 423.1 K | Goldman Sachs Group Inc | 2025-03-31 | 406.7 K | Mesirow Institutional Investment Management, Inc. | 2024-12-31 | 380.4 K | Blackrock Inc | 2025-03-31 | 6.1 M | Vanguard Group Inc | 2025-03-31 | 2.4 M |
Amphastar P Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amphastar insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amphastar's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Amphastar insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Amphastar Outstanding Bonds
Amphastar issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amphastar P uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amphastar bonds can be classified according to their maturity, which is the date when Amphastar P has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| AMPHENOL P NEW Corp BondUS032095AH42 | View | |
| US032095AJ08 Corp BondUS032095AJ08 | View | |
| APH 22 15 SEP 31 Corp BondUS032095AL53 | View | |
| US032095AP67 Corp BondUS032095AP67 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Amphastar Corporate Filings
F4 | 3rd of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 4th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 8th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 14th of April 2025 Other Reports | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Amphastar P offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amphastar's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amphastar P Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amphastar P Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amphastar P. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.37) | Earnings Share 2.76 | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.